The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gardiner Nathaniel S. since 2015.
This trader's CIK number is 1607643.
At the time of last reporting, Gardiner Nathaniel S. was the Chief Legal Officer of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA).
Also see all insider trading activities at Enanta Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | ENTA | 0 | $0 | 0 | $0 | 5,187 | $46,631 |
2023 | ENTA | 0 | $0 | 2,412 | $23,227 | 6,667 | $200,010 |
2020 | ENTA | 0 | $0 | 0 | $0 | 16,833 | $189,990 |
2019 | ENTA | 0 | $0 | 3,270 | $311,562 | 14,406 | $456,226 |
2018 | ENTA | 0 | $0 | 0 | $0 | 7,800 | $270,660 |
2016 | ENTA | 500 | $12,222 | 0 | $0 | 0 | $0 |
2015 | ENTA | 1,400 | $46,485 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-02-26 | ENTA | Option Ex | 5,187 | 8.99 | 46,631 |
2023-12-05 | ENTA | Sale | 2,412 | 9.63 | 23,227 |
2023-04-18 | ENTA | Option Ex | 6,667 | 30.00 | 200,010 |
2020-12-15 | ENTA | Option Ex | 5,250 | .00 | 0 |
2020-12-03 | ENTA | Option Ex | 1,667 | 30.00 | 50,010 |
2020-08-05 | ENTA | Option Ex | 1,666 | 30.00 | 49,980 |
2020-03-12 | ENTA | Option Ex | 3,000 | 30.00 | 90,000 |
2019-12-16 | ENTA | Option Ex | 5,250 | .00 | 0 |
2019-11-22 | ENTA | Option Ex | 1,592 | 31.42 | 50,020 |
2019-09-27 | ENTA | Option Ex | 5,000 | 30.00 | 150,000 |
2019-06-26 | ENTA | Option Ex | 3,295 | 31.42 | 103,528 |
2019-03-06 | ENTA | Option Ex | 2,519 | 33.06 | 83,278 |
2019-02-13 | ENTA | Sale | 3,270 | 95.28 | 311,562 |
2019-01-22 | ENTA | Option Ex | 2,000 | 34.70 | 69,400 |
2018-12-06 | ENTA | Option Ex | 2,000 | 34.70 | 69,400 |
2018-10-01 | ENTA | Option Ex | 1,500 | 34.70 | 52,050 |
2018-02-08 | ENTA | Option Ex | 4,300 | 34.70 | 149,210 |
2016-05-11 | ENTA | Buy | 500 | 24.45 | 12,222 |
2015-02-17 | ENTA | Buy | 1,000 | 33.28 | 33,285 |
2015-02-13 | ENTA | Buy | 400 | 33.00 | 13,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gardiner Nathaniel S. (Chief Legal Officer of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.